BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Julphar
Citi
Cantor Fitzgerald
Chubb
Daiichi Sankyo
QuintilesIMS
Deloitte
Teva
Mallinckrodt

Generated: January 24, 2018

DrugPatentWatch Database Preview

DEXMETHYLPHENIDATE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Dexmethylphenidate Hydrochloride, and when can generic versions of Dexmethylphenidate Hydrochloride launch?

Dexmethylphenidate Hydrochloride is a drug marketed by Impax Labs Inc, Intellipharmaceutics, Mylan Pharms Inc, Par Pharm Inc, Teva Pharms Usa, Abhai Inc, Lannett, Novel Labs Inc, Sun Pharm Industries, Teva Pharms, and Tris Pharma Inc. and is included in fourteen NDAs.

The generic ingredient in DEXMETHYLPHENIDATE HYDROCHLORIDE is dexmethylphenidate hydrochloride. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the dexmethylphenidate hydrochloride profile page.
Summary for DEXMETHYLPHENIDATE HYDROCHLORIDE
Drug patent expirations by year for DEXMETHYLPHENIDATE HYDROCHLORIDE
Pharmacology for DEXMETHYLPHENIDATE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DEXMETHYLPHENIDATE HYDROCHLORIDE

US Patents and Regulatory Information for DEXMETHYLPHENIDATE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Industries DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride TABLET;ORAL 201231-001 Sep 24, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abhai Inc DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride TABLET;ORAL 206931-001 Dec 4, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Tris Pharma Inc DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride TABLET;ORAL 207901-003 Aug 26, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride TABLET;ORAL 077107-001 Jan 29, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 202731-001 Jul 5, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Abhai Inc DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride TABLET;ORAL 206931-002 Dec 4, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 202731-003 May 19, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs Inc DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 079108-001 Aug 5, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm Inc DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 202842-003 Nov 30, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa DEXMETHYLPHENIDATE HYDROCHLORIDE dexmethylphenidate hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 078908-001 Nov 19, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Farmers Insurance
Medtronic
QuintilesIMS
Fuji
Johnson and Johnson
Covington
Accenture
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot